Search

everythinglearnresearchcommunity

for

Search:↓

Some chemotherapy can cause permanent hair loss.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Low-level laser treatment helped rats regrow hair faster after chemotherapy.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Finasteride may improve prostate cancer treatment outcomes.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.